Aflibercept

Medication

About

Thing
Aflibercept, sold under the brandname Eylea and Zaltrap, is a medication used to treat wet macular degeneration and metastatic colorectal cancer. It was developed by Regeneron Pharmaceuticals and is approved in the United States and Europe. It is an inhibitor of vascular endothelial growth factor.
Aflibercept
Definition
Aflibercept, sold under the brandname Eylea and Zaltrap, is a medication used to treat wet macular degeneration and metastatic colorectal cancer. It was developed by Regeneron Pharmaceuticals and is approved in the United States and Europe. It is an inhibitor of vascular endothelial growth factor.
Aflibercept
Aflibercept
Aflibercept, sold under the brandname Eylea and Zaltrap, is a medication used to treat wet macular degeneration and metastatic colorectal cancer. It was developed by Regeneron Pharmaceuticals and is approved in the United States and Europe. It is an inhibitor of vascular endothelial growth factor.

Pronunciation

English

Aflibercept

Aflibercept
SpellingAflibercept
Pronunciation[Aflibercept]
New to Cofactor?

Cofactor is a large, structured listing of people, places, and things. Here you can find the description of each topic.

See also: